N@N

S3 Investment Company Comments on Status of Quarterly Financial Report

^{Published on 2009-11-18 06:48:29 - Market Wire}
 

DANVILLE, CA--(Marketwire - November 18, 2009) - S3 Investment Company, Inc. (PINKSHEETS: [ SIVC ]) today commented on the status of its consolidated financial report for the period ended September 30, 2009, which were scheduled to be posted to the Pink Sheets OTC Disclosure and News Service this week. Due to the turnover in the company's accounting personnel, the quarterly financials will be delayed approximately 30 days and are expected to be filed by December 15, 2009.

"The delay in filing S3's consolidated financial report was somewhat unavoidable given the timing of the transition to our new controller, but we remain committed to reporting financial information within the timeframes required by the Pink Sheets OTC Disclosure and News Service," said S3 Investment Company Chairman and CEO Jim Bickel. "We expect that our next quarterly filing, for the period ending December 31, 2009 will be prepared and submitted on time. Considering the ongoing success of our Redwood Capital subsidiary, including recently closed transactions, and the addition of our new Redwood Medical subsidiary, we will continue to stress detailed and timely financial disclosure for S3."

"As our accounting staff works on the financial reports, we expect to have several additional announcements regarding the business of S3's Redwood subsidiaries in the coming weeks," Mr. Bickel added.

To sign up to receive information by email directly from S3 Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit [ http://www.s3investments.com/investors/ ].

About S3 Investment Company, Inc.

S3 Investment Company, Inc. ([ http://www.s3investments.com ]) and its Redwood Group International subsidiary are focused on facilitating the success of two subsidiaries operating in the China market. Redwood Capital, Inc. assists private Chinese companies in accessing the North American capital markets by utilizing a network of investment banking relationships to achieve reverse merger transactions. For more information, please visit [ http://www.redwoodcapinc.com ]. Redwood Medical, Inc. assists companies seeking to import and distribute Western medical technologies and products into the China market.

Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.